Goodwill and Other Intangible Assets (Tables)
|
12 Months Ended |
Apr. 25, 2025 |
|---|
| Goodwill and Intangible Assets Disclosure [Abstract] |
|
| Schedule of Changes in the Carrying Amount of Goodwill |
The following table presents the changes in the carrying amount of goodwill by segment: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | Cardiovascular | | Neuroscience | | Medical Surgical | | Diabetes | | Total | | April 28, 2023 | $ | 7,873 | | | $ | 11,718 | | | $ | 19,579 | | | $ | 2,255 | | | $ | 41,425 | | | Goodwill as a result of acquisitions | 131 | | | — | | | — | | | — | | | 131 | | | Purchase accounting adjustments | (5) | | | — | | | — | | | — | | | (5) | | | Currency translation and other | (33) | | | (74) | | | (458) | | | — | | | (565) | | | April 26, 2024 | 7,966 | | | 11,644 | | | 19,121 | | | 2,255 | | | 40,986 | | | Goodwill as a result of acquisitions | — | | | — | | | 108 | | | — | | | 108 | | | Purchase accounting adjustments | 2 | | | — | | | (2) | | | — | | | — | | | Currency translation and other | 50 | | | 72 | | | 521 | | | 1 | | | 643 | | | April 25, 2025 | $ | 8,017 | | | $ | 11,716 | | | $ | 19,748 | | | $ | 2,255 | | | $ | 41,737 | |
|
| Schedule of Gross Carrying Amount and Accumulated Amortization of Definite-Lived Intangible Assets |
The following table presents the gross carrying amount and accumulated amortization of intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | April 25, 2025 | | April 26, 2024 | | (in millions) | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization | | Definite-lived: | | | | | | | | | Customer-related | $ | 16,550 | | | $ | (9,650) | | | $ | 16,518 | | | $ | (8,689) | | | Purchased technology and patents | 11,600 | | | (7,514) | | | 11,557 | | | (6,868) | | | Trademarks and tradenames | 421 | | | (283) | | | 424 | | | (274) | | | Other | 355 | | | (101) | | | 256 | | | (84) | | | Total | $ | 28,925 | | | $ | (17,547) | | | $ | 28,755 | | | $ | (15,915) | | | Indefinite-lived: | | | | | | | | | IPR&D | $ | 289 | | | $ | — | | | $ | 385 | | | $ | — | |
|
| Schedule of Gross Carrying Amount of Indefinite-Lived Intangible Assets |
The following table presents the gross carrying amount and accumulated amortization of intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | April 25, 2025 | | April 26, 2024 | | (in millions) | Gross Carrying Amount | | Accumulated Amortization | | Gross Carrying Amount | | Accumulated Amortization | | Definite-lived: | | | | | | | | | Customer-related | $ | 16,550 | | | $ | (9,650) | | | $ | 16,518 | | | $ | (8,689) | | | Purchased technology and patents | 11,600 | | | (7,514) | | | 11,557 | | | (6,868) | | | Trademarks and tradenames | 421 | | | (283) | | | 424 | | | (274) | | | Other | 355 | | | (101) | | | 256 | | | (84) | | | Total | $ | 28,925 | | | $ | (17,547) | | | $ | 28,755 | | | $ | (15,915) | | | Indefinite-lived: | | | | | | | | | IPR&D | $ | 289 | | | $ | — | | | $ | 385 | | | $ | — | |
|
| Schedule of Estimated Future Aggregate Amortization Expense, Definite-Lived Intangible Assets |
Estimated aggregate amortization expense by fiscal year based on the current carrying value and remaining estimated useful lives of definite-lived intangible assets at April 25, 2025, excluding any possible future amortization associated with acquired IPR&D which has not met technological feasibility, is as follows: | | | | | | | (in millions) | Amortization
Expense | | 2026 | $ | 1,677 | | | 2027 | 1,654 | | | 2028 | 1,582 | | | 2029 | 1,479 | | | 2030 | 1,343 | |
|